Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis

Cutting Edge: TGF- -Induced Expression of Foxp3 in T cells Is Mediated through Inactivation of ERK

(2014) X. Luo et al.   JOURNAL OF IMMUNOLOGY

Improved Cardiac Performance by Rosuvastatin Is Associated With Attenuations in Both Myocardial Tumor Necrosis Factor-α and p38MAP Kinase Activity in Rats After Myocardial Infarction

(2010) Yingying Xu et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Is there an anti-inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database

(2009) Sara Lodi et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis

(2008) H Kelchtermans et al.   ANNALS OF THE RHEUMATIC DISEASES

CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis

(2008) Guang Ming Han et al.   CELLULAR IMMUNOLOGY

Human regulatory T cells: role in autoimmune disease and therapeutic opportunities

(2008) Todd M. Brusko et al.   IMMUNOLOGICAL REVIEWS

Atorvastatin Modulates Th1/Th2 Response in Patients With Chronic Heart Failure

(2008) Xiang Cheng et al.   JOURNAL OF CARDIAC FAILURE

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

(2008) S. Sauer et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

(2007) Karin Mausner-Fainberg et al.   ATHEROSCLEROSIS